Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ON-Bipolar Cell Transduction via rAAV2-Mediated Gene Transfer (rAAV2-ON-Bipolar Cell Transduction)
- Target
- rAAV2-ON-Bipolar Cell Transduction
- Molecular classification
- Gene Therapy, Viral Vector, rAAV2 vector, Gene Delivery System
01
Overview
ON-bipolar cell transduction via rAAV2-mediated gene transfer is a gene therapy approach for targeting ON-bipolar cells in the retina. It utilizes engineered rAAV2 vectors with optimized capsids and cell-specific promoters (Grm6) to selectively deliver therapeutic genes to ON-bipolar cells. This approach is used for vision restoration through optogenetics or to treat inherited retinal diseases.
- Other names
- rAAV2-mediated ON-bipolar cell gene therapyON-bipolar cell specific gene deliveryGrm6 promoter-driven rAAV2 transduction
02
Mechanism of action
rAAV2 vectors, modified for improved tropism and promoter specificity, deliver therapeutic genes to ON-bipolar cells within the retina. The Grm6 promoter restricts gene expression to ON-bipolar cells, and capsid modifications enhance transduction efficiency. This targeted gene delivery can restore function through optogenetics or by delivering therapeutic genes to correct genetic defects.
03
Biological functions
Gene transferOptogenetic stimulationTherapeutic gene deliveryRetinal signal transduction modulation
04
Disease associations
Retinal degenerationInherited retinal diseases
05
Safety considerations
Off-target transductionImmunogenicity of AAV vectorInsertional mutagenesisPre-existing immunity to AAV
Beyond the preview
Go deeper on ON-Bipolar Cell Transduction via rAAV2-Mediated Gene Transfer (rAAV2-ON-Bipolar Cell Transduction).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ON-Bipolar Cell Transduction via rAAV2-Mediated Gene Transfer (rAAV2-ON-Bipolar Cell Transduction).